Combined use of aspirin and a high-dose proton pump inhibitor (PPI) protects against the development of esophageal cancer in people who are at elevated risk for the malignancy, according to the results of a major phase 3 chemoprevention trial from the United Kingdom, the Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia (AspECT) trial. Dr Janusz…
Category: post
Combo Of RT And Chemotherapy: Best For Early FL
For the management of early-stage follicular lymphoma (FL), a randomized trial shows that the combination of radiotherapy (RT) with chemo immunotherapy gives better clinical outcomes that treatment with radiation alone, and the researchers reporting these results say that they should change clinical practice. After a median follow-up of 9.6 years, the estimated 10-year progression-free survival…
Drug Combination Shows Promise In Advanced Prostrate Cancer.
Adding the poly ADP ribose polymerase (PARP) inhibitor olaparib (Lynparza, AstraZeneca) to the androgen synthesis inhibitor abiraterone acetate (Zytiga, Janssen) significantly improves progression-free survival (PFS) in men with advanced prostate cancer over abiraterone alone, UK researchers have discovered. Studying 142 patients with metastatic castration-resistant prostate cancer (mCRPC), Dr Noel Clarke, The Christie and Salford Royal…
You are invited to the 4th anniversary of GDMeds
4 years ago, Dr. Liya started her business aim to help her clients, and try her best to make it reliable and affordable. Up to date, she still sticks to this mission and never changes. Furthermore, to serve our clients better, this year, Apr 2018, we move to the new e-platform (GDMeds.com). We hope all…
Next-Gen Sequencing for Lung Cancer: Do It Early, for All of Your Patients
Next-Gen Sequencing for Lung Cancer: Do It Early, for All of Your Patients Author: Mark G. Kris, MD Mark Kris from Memorial Sloan Kettering in New York City, talking, once again, about the benefits of doing next-generation sequencing (NGS) at diagnosis on persons with lung cancer. We’ve talked before about the need to get this…
Uveal Melanoma: Better Survival With Liver Directed Therapy.
For patients with uveal melanoma, the most common eye cancer in adults, survival outcomes have improved in recent years, after treatment modalities shifted from systemic to liver-directed therapies. The finding comes from researchers at the Thomas Jefferson University in Philadelphia, Pennsylvania, and was presented at the recent American Society of Clinical Oncology (ASCO) 2018…
FDA Approves Pegfilgrastim Biosimilar for Cancer Infection Risk
Author: Nick Mulcahy The U.S. Food and Drug Administration has approved the first biosimilar to pegfilgrastim (Neulasta, Amgen), a granulocyte colony-stimulating factor used to reduce infection risk in patients with cancer. The new product is pegfilgrastim-jmdb ( Fulphila , Mylan GmbH), approved for use to decrease the risk for infection in patients with nonmyeloid cancer who are receiving…
Financial Stress A Key Factor In Cancer Patient Care Plan.
Patients with cancer are at a high risk for “financial toxicity,” and nurses need to be equipped to talk to them about the financial aspects of their care, according to Teresa Hagan Thomas, PhD, RN, from the University of Pittsburgh School of Nursing. It is not only the cost of treatment that contributes to financial…
GDMeds.com explore a new way to serve the people
India’s Trusted Pharmacy: Purchase Cancer Drugs Online in India No more running from one chemist store to another when in need of medicines! GDMeds.com brings to you an online medicine store, which can be accessed for all health needs. We are focused towards making healthcare accessible and affordable, especially for cancer drugs, such as chemotherapy,…
New Research: An Egg A Day Keep Heart Attack Away
Is eating eggs bad for your heart due to their high cholesterol content? You may make mistake, please think again. A large research has now shown that people who eat an egg every day could significantly reduce their risk of cardiovascular diseases. What an interesting thing. “The present study finds that there is an association between…
‘Oncology Done Right Is About Balance’: Weighing Immunotherapy Side Effects
Author: Mark G. Kris, MD Hello. This is Mark Kris from Memorial Sloan Kettering. I am speaking to you today about three papers that appeared in JAMA Oncology on January 11, 2018, dealing with the adverse effects of immune checkpoint inhibitors. There was a commentary and two papers. My issue with these presentations is the lack of discussion of benefits…
Risk of Methotrexate Dosing Errors Prompts EMA Review
Reporter: Megan Brook The European Medicines Agency (EMA) is reviewing the risk of dosing errors with medicines containing methotrexate. The review is based on “continued reports of overdose,” the agency announced today. Methotrexate is used to treat various inflammatory conditions, such as arthritis, psoriasis, and some cancers, such as acute lymphoblastic leukemia. Methotrexate can be taken…
